GOLDLINE PHARMACEUTICAL LIMITE Share Price

GOLDLINE PHARMACEUTICAL LIMITE Share Price

BSE: 544759
|
Pharmaceuticals
₹ 40.75
+₹1.70 (4.35%)
1D
Last updated 17 Jul, 2026, 15:23 IST

GOLDLINE PHARMACEUTICAL LIMITE Share Price Today

As of 20 Jul 2026, GOLDLINE PHARMACEUTICAL LIMITE share price is ₹40.75. The stock opened at ₹38.25, compared to its previous close of ₹39.05. During today's trading session, GOLDLINE PHARMACEUTICAL LIMITE share price moved in the range of ₹38.25 to ₹40.75, with an average price of ₹39.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹38.25 and a high of ₹60.00.

₹38.25
4.35% up today
₹40.75
1D LOW
1D HIGH

GOLDLINE PHARMACEUTICAL LIMITE Returns Calculator

Open
₹38.25
High
₹40.75
Low
₹38.25
Prev. close
₹39.05
Circuit
L
H
₹32.40
₹48.58
52-week
L
H
₹38.25
₹60.00

GOLDLINE PHARMACEUTICAL LIMITE Shareholder Returns

GOLDLINE PHARMACEUTICAL LIMITE Share Price History

Mkt Cap Cr
38.87
P/E
0.00
P/B
1.93
ROE
28.89%
D/E
0.64
ROCE
28.35%
Div. Yield
0.00%
EPS(TTM)
5.97
Turnover
1.86
EV/EBITDA
0.00
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.00%
Quick Ratio
0.00
Curr. Ratio
5.90
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Goldline Pharmaceutical has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Goldline Pharmaceutical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,815.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,92,678.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,61,323.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,14,585.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Zydus Lifesciences1,13,990.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,11,661.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,02,896.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories1,01,067.0024.972.7511.64%0.1513.65%3.320.64%0.6338.68
Aurobindo Pharma89,097.9025.442.359.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,639.3060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

GOLDLINE PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹28.06₹23.57₹19.85
Other Income₹0.00₹0.00₹0.00
Total Revenue₹28.06₹23.57₹19.85
Total Expenses₹24.20₹21.04₹19.45
Profit Before Tax₹3.86₹2.53₹0.40
Tax₹1.02₹0.72₹0.14
Profit After Tax₹2.83₹1.81₹0.26
EPS - Basic₹4.11₹3.01₹0.43
EPS - Diluted₹4.11₹3.01₹0.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹3.86₹2.53₹0.40
Income before WC changes₹5.92₹4.35₹2.40
Change in Assets-₹3.29-₹1.91-₹0.52
Change in Liabilities₹0.60₹0.69₹0.55
Change in WC-₹2.69-₹1.23₹0.03
Cash flow from Operations₹2.32₹2.92₹2.39
Cash flow from Investing₹0.16-₹1.11-₹1.03
Cash flow from Financing-₹2.03-₹1.08-₹1.44
Total Cash Flow₹0.45₹0.74-₹0.09
Cash (Start of the year)₹0.79₹0.05₹0.14
Cash (End of the year)₹1.24₹0.79₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹2.93₹3.43₹2.57
Current Assets₹23.35₹19.50₹16.82
Total Assets₹26.28₹22.93₹19.39
Current Liabilities₹11.77₹10.17₹9.00
Net Current Asset₹11.58₹9.33₹7.83
Non-Current Liabilities₹4.16₹4.90₹4.50
Equity Capital₹10.35₹7.87₹5.89
Total Equity & Liabilities₹26.28₹22.93₹19.39
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
35.61
Neutral
ATR (14)
1.27
Neutral
STOCH(9,6)
53.98
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
18.82
Bullish
UO(9)
47.4
Neutral
ROC(12)
-4.26
Bearish
WillR(14)
-63.46
Neutral
Period
Simple value
Exponential vaue
5D
39.56
39.92
10D
40.58
40.52
20D
41.98
41.36
50D
44.36
0
100D
44.36
0

About GOLDLINE PHARMACEUTICAL LIMITE

GOLDLINE PHARMACEUTICAL LIMITE Share Price
ISIN
INE1CLW01015
Sector Market Cap
₹ 38.87 Cr

GOLDLINE PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: GOLDLINE PHARMACEUTICAL LIMITE reported revenue of ₹31.20 crore in FY26 vs ₹28.06 crore in FY25. It showed an increase of 11.19% on a yearly basis.
  • Operating Profit: GOLDLINE PHARMACEUTICAL LIMITE reported an operating profit of ₹5.39 crore in FY26 vs ₹3.86 crore in FY25. It showed an increase of 39.64% on a year-on-year basis.
  • Net Profit: GOLDLINE PHARMACEUTICAL LIMITE reported a net profit of ₹4.12 crore in FY26 vs ₹2.83 crore in FY25. It showed an increase of 45.58% on a yearly basis.
Know more
Promoters
57.29%
FII
5.16%
Other DII
7.81%
Retail and other
29.74%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
GOLDLINE PHARMACEUTICAL LIMITE Share Price
GOLDLINE PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

FAQs on GOLDLINE PHARMACEUTICAL LIMITE Share Price